Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.
Saved in:
| Title: | Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise. |
|---|---|
| Authors: | Croarkin, Paul E.1 (AUTHOR) croarkin.paul@mayo.edu, Sutherland, Isabella2 (AUTHOR), Ho, Ming-Fen1 (AUTHOR) |
| Source: | Journal of the American Academy of Child & Adolescent Psychiatry. Jul2025, Vol. 64 Issue 7, p756-758. 3p. |
| Subject Terms: | *Teenagers, LSD (Drug), Medical research, Psilocybin, Clinical trials |
| Abstract: | We read with great interest the commentary by Jeffrey et al. entitled "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution."1 We appreciate the efforts of the authors, the scholarship of this commentary, and the advocacy for research initiatives with psychedelic therapeutics such as psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine. We agree that there is a compelling rationale for timely, rigorous studies with adolescents as it is likely that these compounds have been and will be used in adolescents with therapeutic intent. We are writing to catalyze further collegial dialogue and advocacy in our field. We do have some considerations for the authors. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of the American Academy of Child & Adolescent Psychiatry is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Education Research Complete |
Be the first to leave a comment!
